Dr. Henri Wajcman pursues as his research aims
- the molecular characterisation of haemoglobin abnormalities that may cause disorders
- the evaluation of the effects of the various genetic modifiers of haemoglobinopathies
- the development of new strategies and methods to improve genotype and phenotype
characterisation
- the study of rare haemoglobin variants of clinical interest
- the analysis of the effects of á-haemoglobin-stabilising protein.
Dr. Wajcman also aims to render readily available to clinicians,
and other health professionals, precise information concerning haemoglobin disorders.
A relational database of information about haemoglobin variants and mutations that
cause thalassaemia (HbVar) has been developed and is already available on the World
Wide Web.